Pelham Manor, NY, United States of America

Ronald A DePinho

This inventor holds 9 USPTO granted patents and 2 published patent applications. Top assignees: Albert Einstein College of Medicine, Cold Spring Harbor Laboratory, Other. Active years: 1998-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald A DePinho. Retrieved from https://idiyas.com/inventor/ronald-a-depinho-rr6fq1i7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 77.8

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 33(Granted Patents)


Location History:

  • New York, NY (US) (1998 - 2000)
  • Brookline, MA (US) (2001 - 2004)
  • Pelham Manor, NY (US) (1999 - 2005)

Company Filing History:


Years Active: 1998-2005

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Ronald A. DePinho: A Leader in Cancer Research

Introduction: Ronald A. DePinho, based in Pelham Manor, NY, is a distinguished inventor known for his significant contributions to cancer research. Holding a total of 9 patents, his work focuses on innovative methods to inhibit cancer cell proliferation, as well as exploring genetic mechanisms that play a crucial role in aging and disease control.

Latest Patents: Among his latest inventions, DePinho's patent regarding the "Method of inhibiting cell proliferation using an anti-oncogene protein" stands out. This groundbreaking method is based on the discovery that p19 operates as a suppressor of oncogenic transformation by binding to the MDM2 oncoprotein. By blocking MDM2's ability to degrade essential proteins such as p53 and Rb, this method effectively inhibits tumor cell growth when p19 or its mimetic, along with p53, is administered to the cells. Additionally, his patent on "Mouse telomerase reverse transcriptase" introduces innovative enzyme proteins and nucleic acids that have potential applications in controlling cell proliferation and addressing age-related diseases, including cancer.

Career Highlights: DePinho's impressive career includes significant positions, notably at the Albert Einstein College of Medicine, where his research and innovations flourished. His expertise in oncology and molecular biology has made him a prominent figure in the quest for effective cancer treatments.

Collaborations: Throughout his career, DePinho has collaborated with notable individuals such as Nicole Schreiber-Agus and Gregg B. Morin, further enhancing his research impact within the scientific community.

Conclusion: Ronald A. DePinho exemplifies the spirit of innovation within cancer research. Through his inventive approaches and numerous patents, he has made substantial strides in understanding and combating cancer, ultimately contributing to the field of medical science and paving the way for future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…